메뉴 건너뛰기




Volumn 5, Issue 1, 2014, Pages 196-210

Deficiency in p53 is required for doxorubicin induced transcriptional activation of NF-κB target genes in human breast cancer

Author keywords

Breast cancer; Chemoresistance; NF B; p53; Prognosis

Indexed keywords

CXCL1 CHEMOKINE; DOXORUBICIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 8; PROTEIN P53; TRANSCRIPTION FACTOR RELA; ANTINEOPLASTIC ANTIBIOTIC; TP53 PROTEIN, HUMAN;

EID: 84893826335     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.1556     Document Type: Article
Times cited : (42)

References (51)
  • 1
    • 0024602758 scopus 로고
    • Role of DNA breakage in cytotoxicity of doxorubicin, 9-deoxydoxorubicin, and 4-demethyl-6-deoxydoxorubicin in murine leukemia P388 cells
    • Capranico G, De Isabella P, Penco S, Tinelli S and Zunino F. Role of DNA breakage in cytotoxicity of doxorubicin, 9-deoxydoxorubicin, and 4-demethyl-6-deoxydoxorubicin in murine leukemia P388 cells. Cancer Res. 1989; 49(8):2022-2027.
    • (1989) Cancer Res. , vol.49 , Issue.8 , pp. 2022-2027
    • Capranico, G.1    De Isabella, P.2    Penco, S.3    Tinelli, S.4    Zunino, F.5
  • 3
    • 33644538632 scopus 로고    scopus 로고
    • Molecular linkage between the kinase ATM and NF-kappaB signaling in response to genotoxic stimuli
    • Wu ZH, Shi Y, Tibbetts RS and Miyamoto S. Molecular linkage between the kinase ATM and NF-kappaB signaling in response to genotoxic stimuli. Science. 2006; 311(5764):1141-1146.
    • (2006) Science. , vol.311 , Issue.5764 , pp. 1141-1146
    • Wu, Z.H.1    Shi, Y.2    Tibbetts, R.S.3    Miyamoto, S.4
  • 4
    • 0038771214 scopus 로고    scopus 로고
    • Modulation of NF-kappaB activity by exchange of dimers
    • Saccani S, Pantano S and Natoli G. Modulation of NF-kappaB activity by exchange of dimers. Mol Cell. 2003; 11(6):1563-1574.
    • (2003) Mol Cell. , vol.11 , Issue.6 , pp. 1563-1574
    • Saccani, S.1    Pantano, S.2    Natoli, G.3
  • 5
    • 84858734708 scopus 로고    scopus 로고
    • NF-kappaB and chromatin: ten years on the path from basic mechanisms to candidate drugs
    • Natoli G. NF-kappaB and chromatin: ten years on the path from basic mechanisms to candidate drugs. Immunol Rev. 2012; 246(1):183-192.
    • (2012) Immunol Rev. , vol.246 , Issue.1 , pp. 183-192
    • Natoli, G.1
  • 6
    • 84858720357 scopus 로고    scopus 로고
    • Celebrating 25 years of NF-kappaB research
    • Ghosh S and Hayden MS. Celebrating 25 years of NF-kappaB research. Immunol Rev. 2012; 246(1):5-13.
    • (2012) Immunol Rev. , vol.246 , Issue.1 , pp. 5-13
    • Ghosh, S.1    Hayden, M.S.2
  • 9
    • 23044498269 scopus 로고    scopus 로고
    • Inactivation of nuclear factor kappaB by soy isoflavone genistein contributes to increased apoptosis induced by chemotherapeutic agents in human cancer cells
    • Li Y, Ahmed F, Ali S, Philip PA, Kucuk O and Sarkar FH. Inactivation of nuclear factor kappaB by soy isoflavone genistein contributes to increased apoptosis induced by chemotherapeutic agents in human cancer cells. Cancer Res. 2005; 65(15):6934-6942.
    • (2005) Cancer Res. , vol.65 , Issue.15 , pp. 6934-6942
    • Li, Y.1    Ahmed, F.2    Ali, S.3    Philip, P.A.4    Kucuk, O.5    Sarkar, F.H.6
  • 10
    • 0038682199 scopus 로고    scopus 로고
    • Involvement of nuclear transcription factor-kappa B in low-dose doxorubicin-induced drug resistance of cervical carcinoma cells
    • Yeh PY, Chuang SE, Yeh KH, Song YC and Cheng AL. Involvement of nuclear transcription factor-kappa B in low-dose doxorubicin-induced drug resistance of cervical carcinoma cells. Biochem Pharmacol. 2003; 66(1):25-33.
    • (2003) Biochem Pharmacol. , vol.66 , Issue.1 , pp. 25-33
    • Yeh, P.Y.1    Chuang, S.E.2    Yeh, K.H.3    Song, Y.C.4    Cheng, A.L.5
  • 15
    • 77649341172 scopus 로고    scopus 로고
    • Targeting transcription factor NF-kappaB to overcome chemoresistance and radioresistance in cancer therapy
    • Li F and Sethi G. Targeting transcription factor NF-kappaB to overcome chemoresistance and radioresistance in cancer therapy. Biochim Biophys Acta. 2010; 1805(2):167-180.
    • (2010) Biochim Biophys Acta. , vol.1805 , Issue.2 , pp. 167-180
    • Li, F.1    Sethi, G.2
  • 16
    • 20144365514 scopus 로고    scopus 로고
    • Nuclear factor-kappaB induced by doxorubicin is deficient in phosphorylation and acetylation and represses nuclear factor-kappaB-dependent transcription in cancer cells
    • Ho WC, Dickson KM and Barker PA. Nuclear factor-kappaB induced by doxorubicin is deficient in phosphorylation and acetylation and represses nuclear factor-kappaB-dependent transcription in cancer cells. Cancer Res. 2005; 65(10):4273-4281.
    • (2005) Cancer Res. , vol.65 , Issue.10 , pp. 4273-4281
    • Ho, W.C.1    Dickson, K.M.2    Barker, P.A.3
  • 18
    • 84877028141 scopus 로고    scopus 로고
    • Comprehensive molecular portraits of human breast tumours
    • Comprehensive molecular portraits of human breast tumours. Nature. 2012; 490(7418):61-70.
    • (2012) Nature , vol.490 , Issue.7418 , pp. 61-70
  • 20
    • 45149089389 scopus 로고    scopus 로고
    • A comparison between p53 accumulation determined by immunohistochemistry and TP53 mutations as prognostic variables in tumours from breast cancer patients
    • Alsner J, Jensen V, Kyndi M, Offersen BV, Vu P, Borresen-Dale AL and Overgaard J. A comparison between p53 accumulation determined by immunohistochemistry and TP53 mutations as prognostic variables in tumours from breast cancer patients. Acta Oncol. 2008; 47(4):600-607.
    • (2008) Acta Oncol. , vol.47 , Issue.4 , pp. 600-607
    • Alsner, J.1    Jensen, V.2    Kyndi, M.3    Offersen, B.V.4    Vu, P.5    Borresen-Dale, A.L.6    Overgaard, J.7
  • 21
    • 70349173433 scopus 로고    scopus 로고
    • Addressing reported pro-apoptotic functions of NF-kappaB: targeted inhibition of canonical NF-kappaB enhances the apoptotic effects of doxorubicin
    • Bednarski BK, Baldwin AS, Jr. and Kim HJ. Addressing reported pro-apoptotic functions of NF-kappaB: targeted inhibition of canonical NF-kappaB enhances the apoptotic effects of doxorubicin. PLoS One. 2009; 4(9):e6992.
    • (2009) PLoS One. , vol.4 , Issue.9
    • Bednarski, B.K.1    Baldwin, A.S.2    Kim, H.J.3
  • 24
    • 54849417187 scopus 로고    scopus 로고
    • Blockage of NF-kappaB by IKKbeta- or RelA-siRNA rather than the NF-kappaB super-suppressor IkappaBalpha mutant potentiates adriamycin-induced cytotoxicity in lung cancer cells
    • Chen W, Wang X, Bai L, Liang X, Zhuang J and Lin Y. Blockage of NF-kappaB by IKKbeta- or RelA-siRNA rather than the NF-kappaB super-suppressor IkappaBalpha mutant potentiates adriamycin-induced cytotoxicity in lung cancer cells. J Cell Biochem. 2008; 105(2):554-561.
    • (2008) J Cell Biochem. , vol.105 , Issue.2 , pp. 554-561
    • Chen, W.1    Wang, X.2    Bai, L.3    Liang, X.4    Zhuang, J.5    Lin, Y.6
  • 25
    • 1842526076 scopus 로고    scopus 로고
    • Active repression of antiapoptotic gene expression by RelA(p65) NF-kappa B
    • Campbell KJ, Rocha S and Perkins ND. Active repression of antiapoptotic gene expression by RelA(p65) NF-kappa B. Mol Cell. 2004; 13(6):853-865.
    • (2004) Mol Cell. , vol.13 , Issue.6 , pp. 853-865
    • Campbell, K.J.1    Rocha, S.2    Perkins, N.D.3
  • 26
    • 33646555078 scopus 로고    scopus 로고
    • Differential regulation of NF-kappaB activation and function by topoisomerase II inhibitors
    • Campbell KJ, O'Shea JM and Perkins ND. Differential regulation of NF-kappaB activation and function by topoisomerase II inhibitors. BMC Cancer. 2006; 6:101.
    • (2006) BMC Cancer. , vol.6 , pp. 101
    • Campbell, K.J.1    O'Shea, J.M.2    Perkins, N.D.3
  • 28
    • 0033054012 scopus 로고    scopus 로고
    • A20 RNA expression is associated with undifferentiated nasopharyngeal carcinoma and poorly differentiated head and neck squamous cell carcinoma
    • Codd JD, Salisbury JR, Packham G and Nicholson LJ. A20 RNA expression is associated with undifferentiated nasopharyngeal carcinoma and poorly differentiated head and neck squamous cell carcinoma. J Pathol. 1999; 187(5):549-555.
    • (1999) J Pathol. , vol.187 , Issue.5 , pp. 549-555
    • Codd, J.D.1    Salisbury, J.R.2    Packham, G.3    Nicholson, L.J.4
  • 29
    • 34447507710 scopus 로고    scopus 로고
    • A20/TNFAIP3, a new estrogen-regulated gene that confers tamoxifen resistance in breast cancer cells
    • Vendrell JA, Ghayad S, Ben-Larbi S, Dumontet C, Mechti N and Cohen PA. A20/TNFAIP3, a new estrogen-regulated gene that confers tamoxifen resistance in breast cancer cells. Oncogene. 2007; 26(32):4656-4667.
    • (2007) Oncogene. , vol.26 , Issue.32 , pp. 4656-4667
    • Vendrell, J.A.1    Ghayad, S.2    Ben-Larbi, S.3    Dumontet, C.4    Mechti, N.5    Cohen, P.A.6
  • 30
    • 33644822862 scopus 로고    scopus 로고
    • Tumor necrosis factor-alpha-induced protein 3 as a putative regulator of nuclear factor-kappaB-mediated resistance to O6-alkylating agents in human glioblastomas
    • Bredel M, Bredel C, Juric D, Duran GE, Yu RX, Harsh GR, Vogel H, Recht LD, Scheck AC and Sikic BI. Tumor necrosis factor-alpha-induced protein 3 as a putative regulator of nuclear factor-kappaB-mediated resistance to O6-alkylating agents in human glioblastomas. J Clin Oncol. 2006; 24(2):274-287.
    • (2006) J Clin Oncol. , vol.24 , Issue.2 , pp. 274-287
    • Bredel, M.1    Bredel, C.2    Juric, D.3    Duran, G.E.4    Yu, R.X.5    Harsh, G.R.6    Vogel, H.7    Recht, L.D.8    Scheck, A.C.9    Sikic, B.I.10
  • 31
    • 53449093919 scopus 로고    scopus 로고
    • The antitumor activity of an anti-CD54 antibody in SCID mice xenografted with human breast, prostate, non-small cell lung, and pancreatic tumor cell lines
    • Brooks KJ, Coleman EJ and Vitetta ES. The antitumor activity of an anti-CD54 antibody in SCID mice xenografted with human breast, prostate, non-small cell lung, and pancreatic tumor cell lines. Int J Cancer. 2008; 123(10):2438-2445.
    • (2008) Int J Cancer. , vol.123 , Issue.10 , pp. 2438-2445
    • Brooks, K.J.1    Coleman, E.J.2    Vitetta, E.S.3
  • 32
    • 40949111793 scopus 로고    scopus 로고
    • Cell adhesion molecules, vascular endothelial growth factor, and basic fibroblast growth factor in patients with non-small cell lung cancer treated with chemotherapy with or without bevacizumab--an Eastern Cooperative Oncology Group Study
    • Dowlati A, Gray R, Sandler AB, Schiller JH and Johnson DH. Cell adhesion molecules, vascular endothelial growth factor, and basic fibroblast growth factor in patients with non-small cell lung cancer treated with chemotherapy with or without bevacizumab--an Eastern Cooperative Oncology Group Study. Clin Cancer Res. 2008; 14(5):1407-1412.
    • (2008) Clin Cancer Res. , vol.14 , Issue.5 , pp. 1407-1412
    • Dowlati, A.1    Gray, R.2    Sandler, A.B.3    Schiller, J.H.4    Johnson, D.H.5
  • 34
    • 79961175789 scopus 로고    scopus 로고
    • Influence of a dose-dense adjuvant chemotherapy on sVCAM-1/sICAM-1 serum levels in breast cancer patients with 1-3 positive lymph nodes
    • Eggeman H, Stoblen F, Thill M, Korlach S, Schmid P, Luftner D, Elling D, Taran FA, Kummel S and Landt S. Influence of a dose-dense adjuvant chemotherapy on sVCAM-1/sICAM-1 serum levels in breast cancer patients with 1-3 positive lymph nodes. Anticancer Res. 2011; 31(8):2617-2622.
    • (2011) Anticancer Res. , vol.31 , Issue.8 , pp. 2617-2622
    • Eggeman, H.1    Stoblen, F.2    Thill, M.3    Korlach, S.4    Schmid, P.5    Luftner, D.6    Elling, D.7    Taran, F.A.8    Kummel, S.9    Landt, S.10
  • 35
    • 67651005826 scopus 로고    scopus 로고
    • Abrogation of TGF-beta signaling enhances chemokine production and correlates with prognosis in human breast cancer
    • Bierie B, Chung CH, Parker JS, Stover DG, Cheng N, Chytil A, Aakre M, Shyr Y and Moses HL. Abrogation of TGF-beta signaling enhances chemokine production and correlates with prognosis in human breast cancer. J Clin Invest. 2009; 119(6):1571-1582.
    • (2009) J Clin Invest. , vol.119 , Issue.6 , pp. 1571-1582
    • Bierie, B.1    Chung, C.H.2    Parker, J.S.3    Stover, D.G.4    Cheng, N.5    Chytil, A.6    Aakre, M.7    Shyr, Y.8    Moses, H.L.9
  • 38
    • 0032954928 scopus 로고    scopus 로고
    • Transcriptional cross talk between NF-kappaB and p53
    • Webster GA and Perkins ND. Transcriptional cross talk between NF-kappaB and p53. Mol Cell Biol. 1999; 19(5):3485-3495.
    • (1999) Mol Cell Biol. , vol.19 , Issue.5 , pp. 3485-3495
    • Webster, G.A.1    Perkins, N.D.2
  • 40
    • 12144272815 scopus 로고    scopus 로고
    • Estrogen and progesterone receptor isoforms: clinical significance in breast cancer
    • Fuqua SA and Cui Y. Estrogen and progesterone receptor isoforms: clinical significance in breast cancer. Breast Cancer Res Treat. 2004; 87 Suppl 1:S3-10.
    • (2004) Breast Cancer Res Treat , vol.87 , Issue.SUPPL. 1
    • Fuqua, S.A.1    Cui, Y.2
  • 41
    • 23244447215 scopus 로고    scopus 로고
    • Estrogen receptor inhibits interleukin-6 gene expression by disruption of nuclear factor kappaB transactivation
    • Liu H, Liu K and Bodenner DL. Estrogen receptor inhibits interleukin-6 gene expression by disruption of nuclear factor kappaB transactivation. Cytokine. 2005; 31(4):251-257.
    • (2005) Cytokine. , vol.31 , Issue.4 , pp. 251-257
    • Liu, H.1    Liu, K.2    Bodenner, D.L.3
  • 42
    • 66749103282 scopus 로고    scopus 로고
    • NF-kappaB and estrogen receptor alpha interactions: Differential function in estrogen receptor-negative and -positive hormone-independent breast cancer cells
    • Gionet N, Jansson D, Mader S and Pratt MA. NF-kappaB and estrogen receptor alpha interactions: Differential function in estrogen receptor-negative and -positive hormone-independent breast cancer cells. J Cell Biochem. 2009; 107(3):448-459.
    • (2009) J Cell Biochem. , vol.107 , Issue.3 , pp. 448-459
    • Gionet, N.1    Jansson, D.2    Mader, S.3    Pratt, M.A.4
  • 47
    • 0026072872 scopus 로고
    • Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up
    • Elston CW and Ellis IO. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology. 1991; 19(5):403-410.
    • (1991) Histopathology. , vol.19 , Issue.5 , pp. 403-410
    • Elston, C.W.1    Ellis, I.O.2
  • 50
    • 27244443082 scopus 로고    scopus 로고
    • Proliferation marker Ki-67 in early breast cancer
    • Urruticoechea A, Smith IE and Dowsett M. Proliferation marker Ki-67 in early breast cancer. J Clin Oncol. 2005; 23(28):7212-7220.
    • (2005) J Clin Oncol. , vol.23 , Issue.28 , pp. 7212-7220
    • Urruticoechea, A.1    Smith, I.E.2    Dowsett, M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.